Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,959 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $719.07 | 25 | $0 (2024) |
| QOL Medical, LLC | $311.24 | 13 | $0 (2024) |
| ABBVIE INC. | $264.87 | 14 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $254.73 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $208.73 | 12 | $0 (2024) |
| PFIZER INC. | $178.81 | 10 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $175.24 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $148.74 | 5 | $0 (2022) |
| Lilly USA, LLC | $104.01 | 5 | $0 (2024) |
| Braintree Laboratories, Inc. | $92.82 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,775 | 80 | Janssen Biotech, Inc. ($466.22) |
| 2023 | $694.87 | 31 | QOL Medical, LLC ($234.52) |
| 2022 | $303.07 | 15 | Gilead Sciences, Inc. ($103.49) |
| 2021 | $186.52 | 12 | Gilead Sciences, Inc. ($45.25) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: LIVER DISEASE | ||||||
| 12/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Rare Disease | ||||||
| 11/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $124.89 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: LIVER DISEASE | ||||||
| 10/25/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Rare Disease | ||||||
| 10/14/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: LIVER DISEASE | ||||||
| 10/09/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/30/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 616 | 653 | $205,873 | $49,997 |
| 2022 | 6 | 405 | 424 | $127,888 | $32,023 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 205 | $71,545 | $18,089 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $49,280 | $12,362 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 156 | $36,660 | $9,515 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 115 | 115 | $40,480 | $7,648 | 18.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 47 | 49 | $5,620 | $1,726 | 30.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $2,288 | $658.40 | 28.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 110 | 110 | $38,720 | $8,744 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 94 | $32,806 | $8,683 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 122 | $28,670 | $7,634 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $20,240 | $4,821 | 23.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 35 | 41 | $4,702 | $1,656 | 35.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $2,750 | $483.85 | 17.6% |
About Danielle Andrusko
Danielle Andrusko is a Adult Health healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1285925313.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Danielle Andrusko has received a total of $2,959 in payments from pharmaceutical and medical device companies, with $1,775 received in 2024. These payments were reported across 138 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,959).
As a Medicare-enrolled provider, Andrusko has provided services to 1,021 Medicare beneficiaries, totaling 1,077 services with total Medicare billing of $82,020. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Staten Island, NY
- Active Since 04/24/2011
- Last Updated 03/17/2018
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1285925313
Products in Payments
- STELARA (Biological) $368.31
- TREMFYA (Drug) $345.15
- XIFAXAN (Drug) $240.13
- Sucraid (Drug) $234.52
- RINVOQ (Biological) $200.86
- ENTYVIO (Biological) $193.43
- SIMPONI ARIA (Biological) $131.90
- XELJANZ (Drug) $126.77
- OMVOH (Drug) $104.01
- DUPIXENT (Biological) $94.20
- Vemlidy (Drug) $89.16
- RESMETIROM (Drug) $83.52
- SUTAB (Drug) $79.56
- SUCRAID (Drug) $76.72
- ZENPEP (Drug) $56.57
- VELSIPITY (Drug) $52.04
- REMICADE (Biological) $48.95
- ZEPOSIA (Drug) $42.04
- IQIRVO (Drug) $40.42
- OCALIVA (Drug) $40.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Staten Island
Ms. Arianna Freyre, Np, NP
Adult Health — Payments: $5,423
Mariano Siragusa
Adult Health — Payments: $5,253
Mrs. Michele Mcmurray, Np, NP
Adult Health — Payments: $3,695
Marcia Nieves
Adult Health — Payments: $3,002
Ms. Teresita Aziz, Apn, APN
Adult Health — Payments: $2,509
Mona El-Sherif, Np, NP
Adult Health — Payments: $2,506